Effects of resistance exercise on blood glucose in post-menopausal women with type 1 diabetes
Acute Glycemic Effects of Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
This study tests how different types of resistance exercise can help manage blood sugar levels in post-menopausal women with type 1 diabetes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 16 (estimated) |
| Ages | 45 Years to 75 Years |
| Sex | Female |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Trial ID | NCT05203640 on ClinicalTrials.gov |
What this trial studies
This study investigates how resistance exercise impacts blood glucose levels in post-menopausal women diagnosed with type 1 diabetes. It addresses the significant barriers to physical activity in this population, particularly the fear of hypoglycemia during and after exercise. The research will involve participants performing high and moderate repetition resistance exercises to assess their effects on glucose management. The study aims to fill the knowledge gap regarding exercise recommendations for women with type 1 diabetes, especially after menopause.
Who should consider this trial
Good fit: Ideal candidates for this study are post-menopausal women with type 1 diabetes who are physically able and willing to engage in resistance exercise.
Not a fit: Patients with poorly controlled diabetes, significant cardiovascular issues, or those unable to perform resistance exercises may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide tailored exercise recommendations that improve blood glucose control and overall health for post-menopausal women with type 1 diabetes.
How similar studies have performed: While there is limited research specifically on resistance exercise in post-menopausal women with type 1 diabetes, similar studies in other populations have shown positive outcomes, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * female * type 1 diabetes diagnosed for at least 1 year * at least 12 months since last menstrual period * physically able and willing to perform resistance exercise * HbA1c \< 10% * residing near Edmonton, Alberta / able to attend laboratory based sessions at the University of Alberta Exclusion Criteria: * Individuals with HbA1c \>9.9% * Frequent and unpredictable hypoglycaemia * A change in insulin management strategy within two months of the study * Blood pressure \> 144/95, * Severe peripheral neuropathy, * A history of cardiovascular disease * Musculoskeletal injuries affecting the ability to perform resistance exercise. * Individuals who are treated with medications (other than insulin) that affect glucose metabolism (e.g. atypical antipsychotics, corticosteroids) * A body mass index \>30kg/m2, * Smoking * Moderate to high alcohol intake (\>2 drinks per day)
Where this trial is running
Edmonton, Alberta
- Alberta Diabetes Institute — Edmonton, Alberta, Canada (Recruiting)
Study contacts
- Study coordinator: Jane Yardley, PhD
- Email: jane.yardley@ualberta.ca
- Phone: 780-679-1688
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.